VacV Chief Founder & Chief Scientific Officer Prof. Wang and Chief Medical Officer Prof. Hardev Pandha will be attending 6th Glioblastoma Drug Development Summit on 18-20 February 2025.
“Vital platform to showcase groundbreaking scientific innovations and strategic insights, aiming to bring life-saving treatments closer to reality. With a shared goal of improving the lives of patients, this Summit will foster collaboration to advance the development of effective therapies for GBM and other CNS tumors.”
